Clinical perspectives on the use of composite endpoints
- 1 December 1997
- journal article
- review article
- Published by Elsevier BV in Controlled Clinical Trials
- Vol. 18 (6), 517-529
- https://doi.org/10.1016/s0197-2456(97)00005-6
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The Open-Artery Theory Is Alive and Well -- AgainNew England Journal of Medicine, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionThe Lancet, 1992
- In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparinThe Lancet, 1990
- Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?Circulation, 1989
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Evaluation of the effectiveness of intracoronary streptokinase infusion in acute myocardial infarction: Postprocedure management and hospital course in 204 patientsAmerican Heart Journal, 1981
- Intracoronary thrombolysis in evolving myocardial infarctionAmerican Heart Journal, 1981
- Initial experience with transluminal recanalization of the recently occluded infarct‐related coronary artery in acute myocardial infarction — Comparison with conventionally treated patientsClinical Cardiology, 1979